Contract Research And Manufacturing Services (CRAMS) Market Growth Through 2030 Creates New Strategic Opportunities
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Contract Research And Manufacturing Services (CRAMS) Market Expansion From $171.86 Billion In 2026 To $258.35 Billion In 2030
The market for contract research and manufacturing services (CRAMS) has experienced swift expansion in recent years. Its value is projected to increase from $155.61 billion in 2025 to $171.86 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.4%. This historical growth has been driven by several factors, including the escalation of research and development expenses within the pharmaceutical industry, a heightened need for novel therapeutics, constraints on internal manufacturing capacities, growing complexities in regulatory frameworks, and the rise of biotechnology firms.
The contract research and manufacturing services (CRAMS) market is projected to experience substantial expansion in the coming years, with its value anticipated to reach $258.36 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.7%. This growth during the forecast period is fueled by factors such as the increasing use of biologics and advanced therapies, broader clinical trial outsourcing, a rising demand for personalized medicine, technological progress in manufacturing automation, and a growing reliance on contract manufacturing for medical devices. Key trends shaping the market include the outsourcing of pharmaceutical research and development, the growth of biologics manufacturing services, an increased need for analytical testing and quality control, the expansion of custom synthesis and production services, and the heightened adoption of contract manufacturing for medical devices.
Download A Free Sample Report For Comprehensive Market Insights:
Contract Research And Manufacturing Services (CRAMS) Market Growth Drivers And Industry Catalysts
The growing number of elderly individuals dealing with multiple chronic conditions is anticipated to favorably influence the expansion of the contract research and manufacturing services (CRAMS) market throughout the forecast period. Globally, the elderly demographic is expanding swiftly, and this trend is projected to persist over the coming years. As the geriatric population increases, the occurrence of illnesses like cancer, diabetes, Alzheimer’s, arthritis, and other diseases is likely to climb, thereby boosting the demand for various medications and treatments. Consequently, the requirement for contract research and manufacturing services is expected to rise. For example, in September 2023, the Australian Bureau of Statistics, a national statistical agency, reported that Australia’s population, which stood at 26 million in 2022, is forecasted to reach between 34.3 million and 45.9 million by 2071. Moreover, the median age, currently at 38.5 years, is predicted to increase to a range of 43.8 to 47.6 years. Thus, the expanding elderly population will serve as a key driver for the growth of the contract research and manufacturing services (CRAMS) market.
Contract Research And Manufacturing Services (CRAMS) Market Categorization By Product Type And Application
The contract research and manufacturing services (crams) market covered in this report is segmented –
1) By Services: Manufacturing, Research
2) By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Academic Institutes
3) By Product: API (Active Pharmaceutical Ingredient) Services, Finished Dosage Form (FDF) Services, Biologics / Cell & Gene Therapy Services, Formulation Development & Packaging
Subsegments:
1) By Manufacturing: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Biologics Manufacturing, Contract Manufacturing Of Medical Devices, Formulation Development And Manufacturing, Packaging And Labeling Services, Analytical Testing And Quality Control, Custom Synthesis And Production
2) By Research: Preclinical Research, Clinical Research (Phase I-IV), Drug Discovery And Development Services, Regulatory Affairs And Consulting, Bioanalytical Testing Services, Toxicology Testing, Process Development And Optimization, Clinical Trial Management And Monitoring, Pharmacovigilance And Safety Services
Contract Research And Manufacturing Services (CRAMS) Market Trends Influencing Long-Term Demand
The contract research and manufacturing services (CRAMS) market is increasingly leveraging artificial intelligence (AI) to enhance its competitive standing. AI, a branch of computer science focused on simulating human behavior in machines, enables the prediction of maintenance requirements, thereby preventing costly repairs and supporting healthcare systems. For example, in June 2024, Medidata, a US-based technology company, introduced the Medidata clinical data studio. This platform specializes in integrating and managing clinical trial data from diverse sources, boosting the efficiency and accuracy of clinical research. By employing AI to streamline data review and reconciliation, it helps study teams identify potential data issues and safety signals more effectively. The platform offers a comprehensive workspace for data integration, transformation, and management, empowering users to implement robust risk-based quality management strategies and gain real-time insights.
Contract Research And Manufacturing Services (CRAMS) Market Company Landscape And Strategic Competition
Major companies operating in the contract research and manufacturing services (crams) market are Lonza Group, Catalent Inc., WuXi AppTec, Boehringer Ingelheim, Charles River Laboratories, Jubilant Life Sciences, PRA Health Sciences, Syngene International Ltd., Samsung Biologics, Evotec AG, AMRI (Albany Molecular Research Inc.), Parexel International Corporation, ICON plc, IQVIA Holdings Inc., PPD (Pharmaceutical Product Development), Recipharm AB, Curia Global Inc., Cambrex Corporation, Labcorp Drug Development, CordenPharma, Medpace Holdings Inc., FAMAR Health Care Services, Rentschler Biopharma SE, PCI Pharma Services, Dishman Carbogen Amcis Ltd., Thermo Fisher Scientific Inc., ProPharma Group, Siegfried AG
Access The Complete Contract Research And Manufacturing Services (CRAMS) Market Report:
Contract Research And Manufacturing Services (CRAMS) Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the contract research and manufacturing services (CRAMS) market in 2025. Asia-Pacific region is expected to grow at a faster pace in the forecast period. The regions covered in the contract research and manufacturing services (crams) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
